Paolo Ambrosino Selected Research

KCNQ3 Potassium Channel

3/2015

Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paolo Ambrosino Research Topics

Disease

9	Brain Diseases (Brain Disorder) 11/2023 - 03/2013
9	Epilepsy (Aura) 01/2022 - 06/2009
4	Seizures (Absence Seizure) 01/2024 - 03/2009
4	Pain (Aches) 09/2019 - 03/2013
2	COVID-19 01/2023 - 01/2022
2	Hyperalgesia 07/2018 - 11/2013
2	Benign Neonatal Epilepsy (Benign Familial Neonatal Convulsions) 03/2014 - 01/2011
1	Partial Epilepsies (Epilepsy, Partial) 01/2024
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2023
1	Ataxia (Dyssynergia) 01/2023
1	Infections 01/2023
1	Rare Diseases (Rare Disease) 07/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Neoplasms (Cancer) 12/2020
1	Prostatic Neoplasms (Prostate Cancer) 12/2020
1	Neuralgia (Stump Neuralgia) 07/2017
1	Pathologic Processes 07/2017
1	Hypoxia (Hypoxemia) 05/2016
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2015
1	Infarction (Infarctions) 08/2015
1	Brain Ischemia (Cerebral Ischemia) 08/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2014
1	Stroke (Strokes) 01/2013
1	Convulsions benign familial neonatal dominant form 06/2009

Drug/Important Bio-Agent (IBA)

8	Potassium Channels (Potassium Channel)IBA 11/2023 - 01/2010
3	Anticonvulsants (Antiepileptic Drugs)IBA 03/2013 - 01/2010
2	Fluoxetine (Prozac)FDA LinkGeneric 01/2024 - 01/2023
2	CalciumIBA 12/2020 - 03/2013
2	PotassiumIBA 10/2020 - 06/2009
2	BradykininIBA 09/2019 - 03/2013
2	Capsaicin (Zostrix)FDA Link 09/2019 - 03/2013
2	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2018 - 12/2016
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2018 - 07/2017
2	ezogabine (retigabine)IBA 05/2016 - 01/2010
1	Antidepressive Agents (Antidepressants)IBA 01/2024
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Particulate MatterIBA 01/2023
1	Calcium Carbonate (Limestone)FDA Link 07/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	AntibodiesIBA 01/2022
1	KCNQ2 Potassium ChannelIBA 01/2022
1	CationsIBA 12/2020
1	Transient Receptor Potential ChannelsIBA 12/2020
1	Gabapentin (Neurontin)FDA LinkGeneric 10/2020
1	Quinidine (Chinidin)FDA LinkGeneric 10/2018
1	icilinIBA 07/2018
1	Tryptophan (L-Tryptophan)FDA Link 07/2018
1	allyl isocyanateIBA 07/2017
1	allyl isothiocyanateIBA 07/2017
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 07/2017
1	isothiocyanic acidIBA 07/2017
1	sodium bisulfide (NaHS)IBA 07/2017
1	GasotransmittersIBA 07/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2017
1	IsothiocyanatesIBA 07/2017
1	Hemoglobins (Hemoglobin)IBA 07/2017
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 09/2015
1	5- amino- N- butyl- 2- (4- ethoxyphenoxy)- benzamide hydrochlorideIBA 08/2015
1	Glucose (Dextrose)FDA LinkGeneric 08/2015
1	Oxygen (Dioxygen)IBA 08/2015
1	Sodium-Calcium ExchangerIBA 08/2015
1	Protein Isoforms (Isoforms)IBA 08/2015
1	Dihydrotachysterol (AT 10)IBA 08/2015
1	KCNQ3 Potassium ChannelIBA 03/2015
1	LeptinIBA 09/2014
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 09/2014
1	N-Methylaspartate (NMDA)IBA 09/2014
1	Syntaxin 1IBA 03/2014
1	IsoxazolesIBA 11/2013
1	AntiportersIBA 01/2013
1	7- nitro- 5- phenyl- 1- (pyrrolidin- 1- ylmethyl)- 1H- benzo(e)(1,4)diazepin- 2(3H)- oneIBA 01/2013
1	Neuroprotective AgentsIBA 01/2013

Therapy/Procedure

5	Therapeutics 12/2020 - 01/2010
1	Precision Medicine 01/2023
1	Critical Care (Surgical Intensive Care) 01/2022
1	Drug Therapy (Chemotherapy) 07/2017
1	Intraperitoneal Injections 03/2009